✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Kangji Medical Holdings Ltd

Common Name
Kangji Medical Holdings
Country
China (Mainland)
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
1,007
Ticker
9997
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Kangji Medical Holdings Ltd. is a prominent player in the medical device industry, specializing in the development and manufacturing of minimally invasive surgical instruments and accessories. Establi...

Kangji Medical Holdings's GHG Emissions Data Preview

In 2023, Kangji Medical Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Kangji Medical Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202320222021
2020 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
b
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
0000000
Limited Data Preview
You are viewing a limited preview of Kangji Medical Holdings’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=9997&reporting_period=2024"

Verified Sources Behind Kangji Medical Holdings’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kangji Medical Holdings’s data sources below and access millions more through our Disclosure Search.

a. Kangji Medical Holdings's Annual Report 2023
b. Kangji Medical Holdings's Annual Report 2022

Insights into Kangji Medical Holdings's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Kangji Medical Holdings amounted to 3,920.71 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Kangji Medical Holdings increased by 12.96%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Kangji Medical Holdings's Scope 1 Emissions Over Time

20212022202304590135180tCO2e+14%+13%
  • Total Scope 1
  • Year-over-Year Change

What are Kangji Medical Holdings's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Kangji Medical Holdings were 164.22 metric tons of CO₂ equivalent (tCO₂e).a

Has Kangji Medical Holdings reduced its Scope 1 emissions over time?

Since 2021, Kangji Medical Holdings's Scope 1 emissions have increased by 29.15%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2022), Kangji Medical Holdings's Scope 1 emissions increased by 12.85%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Kangji Medical Holdings's Scope 2 emissions?

In 2023, Kangji Medical Holdings reported Scope 2 greenhouse gas (GHG) emissions of 3,756.49 tCO₂e without specifying the calculation method.a

Has Kangji Medical Holdings reduced its Scope 2 emissions over time?

Since 2021, Kangji Medical Holdings's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 45.31%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2022), Kangji Medical Holdings's Scope 2 emissions (Unspecified Calculation Method) rose by 12.96% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Kangji Medical Holdings use for Scope 2 reporting?

In 2023, Kangji Medical Holdings reported its Scope 2 emissions using an unspecified methodology.a

Kangji Medical Holdings's Scope 2 Emissions Over Time

20212022202309501.9 k2.85 k3.8 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Kangji Medical Holdings’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Kangji Medical Holdings reported Scope 1 greenhouse gas (GHG) emissions of 164.22 tCO₂e and total revenues of USD 143 millions. This translates into an emissions intensity of 1.15 tCO₂e per millions USD.a

Kangji Medical Holdings's Scope 1 Emissions Intensity Compared to Peers

0.5502,000200,00010,000,000Scope 1 Emissions (tCO2e)5502002,00020,000Revenues (Millions of USD)CAWHICCDTJinxin Fertility GroupYear: 2024Scope 1: 1,017 tCO2eRevenue: $M 421Scope 1 Intensity: 2.41 tCO2e/$MCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MCCCR MedicalYear: 2023Scope 1: 1,359 tCO2eRevenue: $M 1,556Scope 1 Intensity: 0.87 tCO2e/$MLifeTech ScientificYear: 2023Scope 1: 1,528 tCO2eRevenue: $M 195Scope 1 Intensity: 7.84 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MEverest MedicinesYear: 2024Scope 1: 1 tCO2eRevenue: $M 106Scope 1 Intensity: 0.00 tCO2e/$MWWWinner MedicalYear: 2024Scope 1: 32,223 tCO2eRevenue: $M 1,230Scope 1 Intensity: 26.19 tCO2e/$MHHHygeia Healthcare HoldingsYear: 2023Scope 1: 2,681 tCO2eRevenue: $M 627Scope 1 Intensity: 4.27 tCO2e/$MJoinn Laboratories ChinaYear: 2023Scope 1: 319 tCO2eRevenue: $M 334Scope 1 Intensity: 0.96 tCO2e/$MIIImeik Technology DevelopmentYear: 2024Scope 1: 1,252 tCO2eRevenue: $M 415Scope 1 Intensity: 3.02 tCO2e/$MWeigao GroupYear: 2024Scope 1: 3,096 tCO2eRevenue: $M 1,952Scope 1 Intensity: 1.59 tCO2e/$MCCChina Evergrande New Energy Vehicle GroupYear: 2023Scope 1: 1,029 tCO2eRevenue: $M 206Scope 1 Intensity: 4.99 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MCCChina National MedicinesYear: 2024Scope 1: 907 tCO2eRevenue: $M 6,934Scope 1 Intensity: 0.13 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MTTTong Ren Tang TechnologiesYear: 2024Scope 1: 30,000 tCO2eRevenue: $M 1,086Scope 1 Intensity: 27.62 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAngelalign TechnologyYear: 2023Scope 1: 8 tCO2eRevenue: $M 229Scope 1 Intensity: 0.03 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MKangji Medical HoldingsYear: 2023Scope 1: 164 tCO2eRevenue: $M 143Scope 1 Intensity: 1.15 tCO2e/$M

How does Kangji Medical Holdings's GHG emissions intensity compare to its peers?

In 2023, Kangji Medical Holdings reported a Scope 1 emissions intensity of 1.15 tCO₂e per millions USD. Compared to the peer group median of 3.76, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Kangji Medical Holdings rank on GHG emissions intensity within its industry?

In 2023, Kangji Medical Holdings ranked 7 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Kangji Medical Holdings is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Kangji Medical Holdings's GHG Emissions Dataset?
Start 30-Day Free Trial